Hyper-Interferon Sensitive influenza induces adaptive immune responses and overcomes resistance to anti-PD-1 in murine non-small cell lung cancer

By sjmartinez • September 27, 2024

Du Y, Salehi-Rad R, Zhang TH, Crosson WP, Abascal J, Chen D, Shi Y, Jiang H, Tseng YW, Ma X, Hong M, Wang S, Wang X, Tang K, Hu S, Li Y, Ni S, Cai Y, Tappuni S, Shen Y, Liu B, Sun R. Hyper-Interferon Sensitive influenza induces adaptive immune responses and overcomes resist a nce to anti-PD-1 in murine non-small cell lung cancer. Cancer Immunol Res. 2024 Sep 26. doi: 10.1158/2326-6066.CIR-23-1075. Epub ahead of print. PMID: 39325056.

Tags: Post Doc, Publications, Pulmonary, Critical Care & Sleep Medicine, Veterans Administration

Using priorities between human and livestock bacterial antimicrobial resistance (AMR) to identify data gaps in livestock AMR surveillance

Venkateswaran N, Swetschinski LR, Fastl C, Bari CD, Criscuolo NG, Mulchandani R, Zhao C, Meštrović T, Ikuta KS, Martins SB, Coyne LA, Afonso JS, Huntington[...]

Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data

Murthy V, Voter AF, Nguyen K, Allen-Auerbach M, Chen L, Caputo S, Ledet E, Akerele A, Tuchayi AM, Lawhn-Heath C, Wang T, Carducci MA, Pomper[...]

Efficacy and safety of selexipag in patients with inoperable or persistent/recurrent CTEPH (SELECT randomised trial)

Kim NH, Channick R, Delcroix M, Madani M, Pepke-Zaba J, Borissoff JI, Easton V, Gesang S, Richard D, Ghofrani HA. Efficacy and safety of selexipag[...]